Acylated mono-, bis- and tris-cinchona-based amines containing ferrocene or organic residues: Synthesis, structure and in vitro antitumor activity on selected human cancer cell lines

Molecules

Volumn 17, Issue 3, 2012, Pages 2316-2329

  Károlyi, Benedek Imre ^a   Bosze, Szilvia ^b   Orbán, Erika ^b   Sohár, Pál ^a   Drahos, László ^c   Gál, Emese ^d   Csámpai, Antal ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c CHEMICAL RESEARCH CENTER   (Hungary)

^d BABE BOLYAI UNIVERSITY   (Romania)

Author keywords

Activity; Anticancer; Axial; Ferrocene; In vitro assay; Quinine; Symmetry

Indexed keywords

AMINE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; FERROCENE; FERROUS ION; QUININE;

ACYLATION; ARTICLE; CHEMICAL MODEL; CHEMISTRY; COMPUTER SIMULATION; CONFORMATION; HUMAN; IC 50; SYNTHESIS; TUMOR CELL LINE;

ACYLATION; AMINES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COMPUTER SIMULATION; FERROUS COMPOUNDS; HUMANS; INHIBITORY CONCENTRATION 50; MODELS, CHEMICAL; MOLECULAR CONFORMATION; QUININE;

EID: 84858967016     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17032316     Document Type: Article

References (50)

1. Ding, Y.; Bao, Y.; An, L. Progress in antitumor agents, vinblastine analogues. Zhongguo Yiyao Gongye Zazhi 2005, 36, 424-428.
2. Gao, H. Research status of antitumor drug camptothecin and its derivatives. Hebei Yiyao 2008, 30, 1786-1788.
3. Prudhomme, M. Staurosporines and structurally related indolocarbazoles as antitumor agents. Anticancer Agents Nat. Prod. 2005, 499-517.
4. Ohashi, M.; Oki, T. Ellipticine and related anticancer agents. Expert Opin. Ther. Pat. 1996, 6, 1285-1294. (Pubitemid 26426149)
5. Kaur, K.; Jain, M.; Reddy, R. P.; Jain, R. Quinolines and structurally related heterocycles as antimalarials. Eur. J. Med. Chem. 2010, 45, 3245-3264.
6. Wolf, R.; Baroni, A.; Greco, R.; Donnarumma, G.; Ruocco, E.; Tufano, M. A.; Ruocco, V. Quinine sulfate and bacterial invasion. Ann. Clin. Microbiol. Antimicrob. 2002, 1-5.
7. Kelsey, F. E.; Brunschwig, A. Concentration of quinine in gastrointestinal cancers; preliminary report. Cancer Res. 1947, 7, 355-356.
8. Kim, J.; Lee, K.; Jung, W.; Lee, O.; Kim, T.; Kim, H.; Lee, J.; Passaro, D. J. Validity of serum pepsinogen levels and quininium resin test combined for gastric cancer screening. Cancer Detect. Prev. 2005, 29, 570-575. (Pubitemid 41758497)
9. Lehnert, M.; Dalton, W. S.; Roe, D.; Emerson, S.; Salmon, S. E. Synergistic inhibition by verapamil and quinine of P-glycoprotein-mediated multidrug resistance in a human myeloma cell line model. Blood 1991, 77, 348-354.
10. Taylor, C. W.; Dalton, W. S.; Mosley, K.; Dorr, R. T.; Salmon, S. E. Combination chemotherapy with cyclophosphamide, vincristine, adriamycin, and dexamethasone (CVAD) plus oral quinine and verapamil in patients with advanced breast cancer. Breast Cancer Res. Treat. 1997, 42, 7-14. (Pubitemid 27056723)
11. Genne, P.; Dimanche-Boitrel, M. T.; Mauvernay, R. Y.; Gutierrez, G.; Duchamp, O.; Petit, J. M.; Martin, F.; Chauffert, B. Cinchonine, a potent efflux inhibitor to circumvent anthracycline resistance in vivo. Cancer Res. 1992, 52, 2797-2801.
12. Baraniak, D.; Kacprzak, K.; Celewicz, L. Synthesis of 3'-azido-3'-deoxythymidine (AZT) cinchona alkaloid conjugates via click chemistry: Toward novel fluorescent markers and cytostatic agents. Bioorg. Med. Chem. Lett. 2011, 21, 723-726.
13. Sohue, N. Quinine derivatives and the transplantable tumor. III. The effect of quinine derivatives upon the growth rate of Fujinawa's rat sarcoma in the tissue culture. Folia Pharm. Jpn. 1941, 31, 1-7.
14. Sakai, S.; Minoda, K.; Saito, G.; Akagi, S.; Ueno, A.; Fukuoka, F. The anticancer action of quinoline derivatives. Gann 1955, 46, 605-616.
15. Fiorina, V. J.; Dubois, R. J.; Brynes, S. Ferrocenyl polyamines as agents for the chemoimmunotherapy of cancer. J. Med. Chem. 1978, 21, 393-395. (Pubitemid 8324570)
16. Koepf-Maier, P.; Koepf, H.; Neuse, E. W. Ferrocenium salts-The first antitumor iron compounds. Angew. Chem. Int. Ed. 1984, 96, 446-447.
17. Neuse, E. W.; Kanzawa, F. Evaluation of the activity of some water-soluble ferrocene and ferricenium compounds against carcinoma of the lung by the human tumor clonogenic assay. Appl. Org.-Met. Chem. 1990, 4, 19-26.
18. Snegur, L. V.; Nekrasov, S. Yu., Gumenyuk, V. V.; Zhilina, Z. V.; Morozova, N. B.; Skviridova, I. K.; Rodina, I. A.; Sergeeva, N. S.; Shchitkov, K. G.; et al. Ferrocenylalkylazoles, a new class of lowtoxicity compounds with antitumor activity. Rossiiskii Khim. Zhurn. 1998, 42, 178-183.
19. Osella, D.; Ferrali, M.; Zanello, P.; Laschi, F.; Fontani, M.; Nervi, C.; Cavigiolio, G. On the mechanism of the antitumor activity of ferrocenium derivative. Inorg. Chim. Acta 2000, 306, 42-48.
20. Gormen, M.; Pigeon, P.; Top, S.; Vessieres, A.; Plamont, M. A.; Hillard, E. A.; Jaouen, G. Facile synthesis and strong antiproliferative activity of disubstituted diphenylmethylidenyl-[3]ferrocenophanes on breast and prostate cancer cell lines. Med. Chem. Commun. 2010, 1, 149-151.
21. Monserrat, J. P.; Chabot, G. G.; Hamon, L.; Quentin, L.; Scherman, D.; Jaouen, G.; Hillard, E. A. Synthesis of cytotoxic ferrocenyl flavones via a ferricenium-mediated 1, 6-oxidative cyclization. Chem. Commun. 2010, 46, 5145-5147.
22. Hillard, E. A.; Vessieres, A.; Thouin, L.; Jaouen, G.; Amatore, C. Ferrocene-mediated protoncoupled electron transfer in a series of ferrocifen-type breast-cancer drug candidates. Angew. Chem. Int. Ed. 2006, 45, 285-290. (Pubitemid 43017528)
23. Li, H.; Lv, P.; Yan, T.; Zhu, H. Urea derivatives as anticancer agents. Anticancer Agents Med. Chem. 2009, 9, 471-480.
24. Jordan, A. M.; Khan, T. H.; Malkin, H.; Osborn, H. M. I. Synthesis and analysis of urea and carbamate prodrugs as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT). Bioorg. Med. Chem. 2002, 10, 2625-2633. (Pubitemid 34626225)
25. Ma, Z.; Saluta, G.; Kucera, G. L.; Bierbach, U. Effect of linkage geometry on biological activity in thiourea and guanidine-substituted acridines and platinum-acridines. Bioorg. Med. Chem. Lett. 2008, 18, 3799-3801. (Pubitemid 351802253)
26. Cesarini, S.; Spallarossa, A.; Ranise, A.; Schenone, S.; Rosano, C.; La Colla, P.; Sanna, G.; Busonera, B.; Loddo, R. N-Acylated and N, N'-diacylated imidazolidine-2-thione derivatives and N, N'-diacylated tetrahydropyrimidine-2 (1H)-thione analogues: Synthesis and antiproliferative activity. Euur. J. Med. Chem. 2009, 44, 1106-1118.
27. Rao, X.; Wu, Y.; Song, Z.; Shang, S.; Wang, Z. Synthesis and antitumor activities of unsymmetrically disubstituted acylthioureas fused with hydrophenanthrene structure. Med. Chem. Res. 2011, 20, 333-338.
28. Suda, Y.; Egami, K.; Fujita, H. Preparation of acylthiourea compounds as c-Met kinase inhibitors. PCT Int. Appl. 2009, 79.
29. Ruat, M.; Faure, H.; Traiffort, E.; Schoenfelder, A.; Mann, A.; Taddei, M.; Solinas, A.; Manetti, F. Preparation of aromatic N-acylthiourea and N-acylurea as inhibitors of the Hedgehog protein signalling pathway for the treatment of cancer, neurodegenerative diseases and diabetes. Fr. Demande 2009, 57.
30. Garcia-Martin, F.; Cruz, L. J.; Rodriguez-Mias, R. A.; Giralt, E.; Albericio, F. Design and synthesis of FAJANU: A de Novo C2 symmetric cyclopeptide family. J. Med. Chem. 2008, 51, 3194-3202. (Pubitemid 351821879)
31. Manna, C. M.; Tshuva, E. Y. Markedly different cytotoxicity of the two enantiomers of C2-symmetrical Ti (IV) phenolato complexes; mechanistic implications. Dalton T. 2010, 39, 1182-1184.
32. Rabouin, D.; Perron, V.; N'Zemba, B. C.; Gaudreault, R.; Berube, G. A facile synthesis of C2-symmetric 17b-estradiol dimers. Bioorg. Med. Chem. Lett. 2003, 13, 557-560. (Pubitemid 36259734)
33. Raynes, K.; Galatis, D.; Cowman, A. F.; Tilley, L.; Deady, L. W. Synthesis and activity of some antimalarial bisquinolines. J. Med. Chem. 1995, 38, 204-206.
34. Ayad, F.; Tilley, L.; Deady, L. W. Synthesis, antimalarial activity and inhibition of haem detoxification of novel bisquinolines. Bioorg. Med. Chem. Lett. 2001, 11, 2075-2077. (Pubitemid 32763004)
35. Cowman, A. F.; Deady, L. W.; Deharo, E.; Desneves, J.; Tilley, L. Synthesis and activity of some antimalarial bisquinolinemethanols. Aust. J. Chem. 1997, 50, 1091-1096. (Pubitemid 127580398)
36. Brunner, H.; Buegler, J. Enantioselective catalysis. 106. 9-Amino-(9-deoxy) cinchona alkaloids and their derivatives. B. Soc. Chim. Belg. 1997, 106, 77-84.
37. Vakulya, B.; Varga, S.; Csámpai, A.; Soós, T. Highly enantioselective conjugate addition of nitromethane to chalcones using bifunctional cinchona organocatalysts. Org. Lett. 2005, 7, 1967-1969. (Pubitemid 40732025)
38. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A.; Vreven, T.; Kudin, K. N.; Burant, J. C.; et al. GAUSSIAN 03, Rev. A. 1; Gaussian, Inc.: Pittsburgh, PA, USA, 2003.
39. Galow, T. H.; Rodrigo, J.; Cleary, K.; Cooke, G.; Rotello, V. M. Fluorocarbonylferrocene. A versatile intermediate for ferrocene esters and amides J. Org. Chem. 1999, 64, 3745-3746.
40. Van Leusen, D.; Hessen, B. 1, 1'-Diisocyanoferrocene and a convenient synthesis of ferrocenylamine. Organometallics 2001, 20, 224-226.
41. Yuan, Y.; Ye, S.; Zhang, L.; Wang, B.; Xu, Y.; Wang, J.; Wang, H. Studies on intramolecular hydrogen bonding of 1, 1'-bis[N-formyl-N'-p- chlorophenylthiourea]ferrocene. Inorg. Chim. Acta 1997, 256, 313-318. (Pubitemid 127346632)
42. Slater, T. F.; Sawyer, B.; Sträuli, U. Studies on succinate-tetrazolium reductase systems: III. Points of coupling of four different tetrazolium salts III. Points of coupling of four different tetrazolium salts. Biochim. Biophys. Acta 1963, 77, 383-393.
43. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63. (Pubitemid 14203433)
44. Liu, Y. B.; Peterson, D. A.; Kimura, H.; Schubert, D. Mechanism of cellular 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 1997, 69, 581-593. (Pubitemid 27327958)
45. Altman, F. P. Tetrazolium salts and formazans. Prog. Histochem. Cytochem. 1976, 9, 1-56.
46. Denizot, F.; Lang, R. Rapid colorimetric assay for cell growth and survival: Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 1986, 89, 271-277. (Pubitemid 16080782)
47. Datki, Z.; Juhász, A.; Gálfi, M.; Soós, K.; Papp, R.; Zádori, D.; Penke, B. Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells. Brain Res. Bull. 2003, 62, 223-229. (Pubitemid 38091710)
48. Datki, Z.; Papp, R.; Zádori, D.; Soós, K.; Fülöp, L.; Juhász, A.; Laskay, G.; Hetényi, C.; Mihalik, E.; Zarándi, M.; Penke, B. In vitro model of neurotoxicity of Aβ 1-42 and neuroprotection by a pentapeptide: irreversible events during the first hour. Neurobiol. Dis. 2004, 17, 507-515. (Pubitemid 39574883)
49. Biedler, J. L.; Roffler-Tarlov, S.; Schachner, M.; Freedman, L. S. Multiple Neurotransmitter Synthesis by Human Neuroblastoma Cell Lines and Clones. Cancer Res. 1978, 38, 3751-3757. (Pubitemid 9045201)
50. Biedler, J. L.; Helson, L.; Spengler, B. A. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 1973, 33, 2643-2652.